Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Through FAERS, Sentinel, inspections, and AI tools, it tracks safety, catches hidden risks, and protects millions of patients using low-cost medications.